COVID-19-related adaptations to the implementation and evaluation of a clinic-based intervention designed to improve opioid safety

Anna R Morgan, Michelle A Hendricks, Sanae El Ibrahimi, Sara E Hallvik, Brigit Hatch, Caitlin Dickinson, Dagan Wright, Michael A Fischer

Article Type

Review

Published

This article reviews a multidisciplinary project designed to implement and evaluate clinic-based interventions in Oregon, USA, to improve pain management, opioid prescribing and treatment of opioid use disorder.

Read more

SAFE – Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers

Brianna M McQuade, Mike Koronkowski, Erin Emery-Tiburcio, Robyn Golden, Jennie B Jarrett

Article Type

Original Research

Published

This article discusses the SAFE – Home Opioid Management Education (SAFE-HOME) naloxone awareness program for older adults which utilizes home health workers to educate older adults who are prescribed opioid medications about the access to and use of naloxone to reverse opioid overdose.

Read more

Evaluating the effectiveness of problem-solving courts at preventing fatal and non-fatal opioid events: preliminary findings from Indiana

Elizabeth Van Nostrand, Alyssa Johnston, Steven M Albert, Andre L Brown, Jeanine M Buchanich, Brad Ray, Mark S Roberts

Article Type

Original Research

Published

The aim of this study is to determine which interventions offered by problem-solving courts and correctional facilities impact morbidity and mortality of persons arrested for drug misuse.

Read more

Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis

George J Wan PhD, Ishveen Chopra PhD, John Niewoehner PharmD, Samuel F Hunter MD, PhD

Article Type

Corrigendum

Published

The authors wish to make the following corrections to their article: Wan GJ, Chopra I, Niewoehner J, Hunter SF. Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis. Drugs in Context 2020; 9: 2020-9-4. DOI: 10.7573/dic.2020-9-4

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.